Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Allogene Therapeutics, Inc. (ALLO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
3
| Douglas Earl Martin (GENERAL COUNSEL) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 08/14/2023 |
3
| CHEN YINLIN JACK (SVP, Finance) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 04/26/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/05/2023 |
3
| Smith Lillian (VP, Corporate Counsel) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 01/09/2023 |
3
| Roberts Zachary (EVP of R&D) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 07/12/2022 |
3
| Mayo Stephen (Director) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 01/21/2022 |
3
| TPG GP A, LLC (10% Owner) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 09/20/2021 |
3
| PF Equity Holdings 2 B.V. (10% Owner) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 08/03/2021 |
3
| SATO VICKI L (Director) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 08/03/2021 |
3
| Barrett Elizabeth A. (Director) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 04/22/2020 |
3
| Bhavnagri Veer (General Counsel) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 09/05/2019 |
3
| Amado Rafael (EVP of R&D and CMO) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| PFIZER INC (10% Owner) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| TPG Group Holdings (SBS) Advisors, Inc. (10% Owner) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| Sisitsky Todd Benjamin (Director) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| MESSEMER DEBORAH M. (Director) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| DEYOUNG JOHN A. (Director) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| WITTE OWEN N. (Director) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| Humer Franz B (Director) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| Kazam Joshua A (Director) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| MOORE ALISON (Chief Technical Officer) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| SCHMIDT ERIC THOMAS (CFO) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| Chang David D (President and CEO) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 10/10/2018 |
3
| Belldegrun Arie (10% Owner) has filed a Form 3 on Allogene Therapeutics, Inc. |
|
|